MSCs vs placebo or control
Death during study period · patients with a haematological condition who receive a haematopoietic stem cell transplant as treatment for their condition.
It is very uncertain whether MSCs changes all‐cause mortality (therapeutic trials) (over duration of trial) compared with control/placebo (very low certainty).
1 finding from 1 review
- Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic… 2019 · Cochrane Headline outcomes onlyHR 1.12 [0.8, 1.56]1 study · 244 participantsVery low